Funding for this research was provided by:
European Union (Innoc 11-1.0-15)
Received: 14 September 2017
Accepted: 12 February 2018
First Online: 17 February 2018
Ethics approval and consent to participate
: The study has been approved by the ethics committee of the University of Lübeck (reference number: AZ 16–124). The study is conducted in accordance with the principles laid out in the Declaration of Helsinki and in accordance with the principles of Good Clinical Practice (ICH-GCP E6). Patients are included after giving written informed consent.
: Not applicable.
: D.R. is an associate editor for BMC Cancer. Otherwise, the authors declare that they have no competing interest related to the study presented here.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.